Research output per year
Research output per year
Search results
-
2020
Cell Therapy for Liver Disease: From Promise to Reality
Khan, S., Khan, R. S. & Newsome, P. N., 1 Nov 2020, In: Seminars in Liver Disease. 40, 4, p. 411-425 15 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
2021
Ex situ Normothermic Split Liver Machine Perfusion: Protocol for Robust Comparative Controls in Liver Function Assessment Suitable for Evaluation of Novel Therapeutic Interventions in the Pre-clinical Setting
Attard, J. A., Osei-Bordom, D-C., Boteon, Y., Wallace, L., Ronca, V., Reynolds, G., Perera, M. T. P. R., Oo, Y. H., Mergental, H., Mirza, D. F. & Afford, S. C., 17 Feb 2021, In: Frontiers in Surgery. 8, 627332.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)211 Downloads (Pure) -
Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer
Patten, D. A., Wilkinson, A. L., O'Keeffe, A. & Shetty, S., 22 Sept 2021, (E-pub ahead of print) In: Seminars in Liver Disease. 42, 1, p. 61-76 16 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile30 Downloads (Pure) -
The human liver microenvironment shapes the homing and function of CD4+ T-cell populations
Wiggins, B. G., Pallett, L. J., Li, X., Davies, S. P., Amin, O. E., Gill, U. S., Kucykowicz, S., Patel, A. M., Aliazis, K., Liu, Y. S., Reynolds, G. M., Davidson, B. R., Gander, A., Luong, T. V., Hirschfield, G. M., Kennedy, P. T. F., Huang, Y., Maini, M. K. & Stamataki, Z., 21 Sept 2021, (E-pub ahead of print) In: Gut.Research output: Contribution to journal › Article › peer-review
Open AccessFile44 Downloads (Pure) -
2023
Liver disease and cell therapy - advances made and remaining challenges
Khan, S., Mahgoub, S., Fallatah, N., Lalor, P. F. & Newsome, P. N., 13 Apr 2023, In: Stem Cells. 41, 8Research output: Contribution to journal › Article › peer-review
-
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
NN9931-4492 investigators, Jun 2023, In: The Lancet Gastroenterology & Hepatology. 8, 6, p. 511-522 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile8 Downloads (Pure) -
TGFβ1 priming enhances CXCR3-mediated mesenchymal stromal cell engraftment to the liver and enhances anti-inflammatory efficacy
Garg, A., Khan, S., Luu, N., Nicholas, D. J., Day, V., King, A. L., Fear, J., Lalor, P. F. & Newsome, P. N., Mar 2023, In: Journal of Cellular and Molecular Medicine. 27, 6, p. 864-878 15 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile32 Downloads (Pure)